New research shows 99 percent of former professional football players surveyed by the Gridiron Greats Assistance Fund, Inc., have suffered a head injury, …
In a research report released today, Cowen analyst Ritu Baral downgraded shares of Avanir Pharmaceuticals (NASDAQ:AVNR) from Outperform to Market Perform rating, and reduced her price …
Cowen analyst Ritu Baral maintained an Outperform rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $20 price target, following the news that the company has entered …
Cowen analyst Ritu Baral reiterated an Outperform rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $20 price target, following the news that the FDA has …
In a research report sent to investors today, Deutsche Bank analyst Alethia Young initiated coverage on Avanir Pharmaceuticals (NASDAQ:AVNR) with a Buy rating and a $17 price …
